View ValuationHuafon ChemicalLtd 향후 성장Future 기준 점검 2/6Huafon ChemicalLtd (는) 각각 연간 21.6% 및 4.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 21.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.1% 로 예상됩니다.핵심 정보21.6%이익 성장률21.77%EPS 성장률Chemicals 이익 성장30.4%매출 성장률4.8%향후 자기자본이익률11.13%애널리스트 커버리지Low마지막 업데이트21 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 16Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China공시 • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 22, 2026Huafon Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 22, 2026공시 • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Mar 28, 2026Huafon Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Mar 28, 2026공시 • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 25, 2025Huafon Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 25, 2025공시 • Sep 04Huafon Chemical Co.,Ltd Proposes Interim Cash Dividend for the Year 2025Huafon Chemical Co.,Ltd proposed interim cash dividend of CNY 0.50000000 per 10 shares for the year 2025.공시 • Jul 02Huafon Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 12, 2025Huafon Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 12, 2025공시 • Apr 01Huafon Chemical Co.,Ltd Proposes Final Cash Dividend for the Year 2024Huafon Chemical Co.,Ltd announced that on 31 March 2025 the profit distribution proposal for 2024: Cash dividend (tax included) of CNY 1.50000000 per 10 shares.공시 • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 26, 2025Huafon Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 26, 2025공시 • Mar 29Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China공시 • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Mar 29, 2025Huafon Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Mar 29, 2025공시 • Oct 31Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd.Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd. on October 28, 2024. The consideration consist of cash and common equity.공시 • Oct 30Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua.Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua on October 28, 2024. Huafon Chemical intends to acquire 100% of the equity of Zhejiang Huafon Synthetic Resin through issuing shares and paying cash. After the agreement is signed, both parties will continue to actively communicate, verify, and negotiate specific details of the transaction plan, transaction method, transaction price, share issuance price, share issuance quantity, and other matters, and will subsequently sign all formal agreements related to this transaction.Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.12 in 3Q 2023). Revenue: CN¥6.63b (down 6.1% from 3Q 2023). Net income: CN¥496.5m (down 13% from 3Q 2023). Profit margin: 7.5% (down from 8.1% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.공시 • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 26, 2024Huafon Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥7.78, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.79 per share.Reported Earnings • Aug 10Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥7.09b (up 10% from 2Q 2023). Net income: CN¥834.7m (up 15% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.공시 • Jun 29Huafon Chemical Co.,Ltd to Report First Half, 2024 Results on Aug 10, 2024Huafon Chemical Co.,Ltd announced that they will report first half, 2024 results on Aug 10, 2024공시 • May 28Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024, at 14:30 China Standard Time. Location: 2F, No. 1688, Development Zone Avenue, Economic Development Zone, Rui'an, Zhejiang ChinaReported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.13 in 1Q 2023). Revenue: CN¥6.66b (up 7.5% from 1Q 2023). Net income: CN¥683.4m (up 8.2% from 1Q 2023). Profit margin: 10% (in line with 1Q 2023). Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.공시 • Mar 30Huafon Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024Valuation Update With 7 Day Price Move • Feb 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥6.99, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.68 per share.공시 • Dec 30Huafon Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.004 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.12 (up from CN¥0.004 in 3Q 2022). Revenue: CN¥7.06b (up 16% from 3Q 2022). Net income: CN¥569.9m (up CN¥548.7m from 3Q 2022). Profit margin: 8.1% (up from 0.3% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.21 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.21 in 2Q 2022). Revenue: CN¥6.43b (down 1.7% from 2Q 2022). Net income: CN¥727.2m (down 30% from 2Q 2022). Profit margin: 11% (down from 16% in 2Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.공시 • Jul 01Huafon Chemical Co., Ltd. to Report First Half, 2023 Results on Aug 11, 2023Huafon Chemical Co., Ltd. announced that they will report first half, 2023 results on Aug 11, 2023공시 • Jun 09Huafon Chemical Co., Ltd. Approves the Cash Dividend for the Year 2022Huafon Chemical Co., Ltd. approved the Cash dividend (tax included) of CNY 1.50000000 per 10 shares for the year 2022, at the AGM held on June 7, 2023.공시 • May 19Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2023 estimated continuing connected transactions; to consider confirmation of 2022 remuneration for directors, supervisors and senior management; and to consider other mattters.Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.29 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.29 in 1Q 2022). Revenue: CN¥6.19b (down 15% from 1Q 2022). Net income: CN¥631.4m (down 54% from 1Q 2022). Profit margin: 10% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Dec 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.0%. The fair value is estimated to be CN¥9.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 19% in 2 years. Earnings is forecast to grow by 23% in the next 2 years.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.004 (vs CN¥0.49 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.004 (down from CN¥0.49 in 3Q 2021). Revenue: CN¥6.10b (down 25% from 3Q 2021). Net income: CN¥21.2m (down 99% from 3Q 2021). Profit margin: 0.3% (down from 28% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.48 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.48 in 2Q 2021). Revenue: CN¥6.54b (down 7.8% from 2Q 2021). Net income: CN¥1.03b (down 53% from 2Q 2021). Profit margin: 16% (down from 31% in 2Q 2021). The decrease in margin was primarily driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Jun 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.5%. The fair value is estimated to be CN¥10.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 58%. Revenue is forecast to grow by 6.4% in 2 years. Earnings is forecast to grow by 0.5% in the next 2 years.Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.35 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.29 (down from CN¥0.35 in 1Q 2021). Revenue: CN¥7.29b (up 26% from 1Q 2021). Net income: CN¥1.36b (down 17% from 1Q 2021). Profit margin: 19% (down from 28% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥8.12b (up 111% from 3Q 2020). Net income: CN¥2.28b (up 295% from 3Q 2020). Profit margin: 28% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year and the company’s share price has also increased by 46% per year.Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.085 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.10b (up 104% from 2Q 2020). Net income: CN¥2.21b (up 463% from 2Q 2020). Profit margin: 31% (up from 11% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Apr 13Full year 2020 earnings released: EPS CN¥0.49 (vs CN¥0.43 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥14.7b (up 6.4% from FY 2019). Net income: CN¥2.28b (up 24% from FY 2019). Profit margin: 16% (up from 13% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.06, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 134% over the past three years.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥13.66, the stock is trading at a trailing P/E ratio of 35.3x, down from the previous P/E ratio of 42.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 170%.Is New 90 Day High Low • Feb 20New 90-day high: CN¥16.20The company is up 56% from its price of CN¥10.41 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.24 per share.Is New 90 Day High Low • Jan 21New 90-day high: CN¥13.52The company is up 81% from its price of CN¥7.47 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.05 per share.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥12.26, the stock is trading at a trailing P/E ratio of 31.7x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 148%.Is New 90 Day High Low • Jan 06New 90-day high: CN¥11.51The company is up 56% from its price of CN¥7.40 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.07 per share.Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥9.85, the stock is trading at a trailing P/E ratio of 25.5x, up from the previous P/E ratio of 21.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 111%.Is New 90 Day High Low • Nov 09New 90-day high: CN¥8.99The company is up 25% from its price of CN¥7.20 on 11 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.57 per share.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.11b, down 17% from the prior year. Total revenue was CN¥15.8b over the last 12 months, down 19% from the prior year.이익 및 매출 성장 예측XSEC:002064 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202827,3083,716N/A3,450112/31/202728,2613,575N/A5,053312/31/202627,7413,286N/A4,10323/31/202624,6512,0222,4854,100N/A12/31/202524,1981,8582,0233,740N/A9/30/202524,6681,6673,4754,974N/A6/30/202525,3241,6852,3633,636N/A3/31/202526,5882,0411,9573,189N/A12/31/202426,9312,2201,7313,025N/A9/30/202426,9892,5651,6943,010N/A6/30/202427,4202,6388492,031N/A3/31/202426,7642,5306172,327N/A12/31/202326,2982,4787522,469N/A9/30/202325,6252,357-1,558634N/A6/30/202324,6691,808-3802,224N/A3/31/202324,7832,1131002,442N/A1/1/202325,8842,844-372,570N/A9/30/202227,2934,2263,0895,424N/A6/30/202229,3106,4812,9555,823N/A3/31/202229,8667,6593,5986,029N/A1/1/202228,3677,9374,0206,135N/A9/30/202125,7977,1652,7525,214N/A6/30/202121,5205,4653,2424,836N/A3/31/202117,8933,6473,2995,060N/A12/31/202014,7242,2792,6284,209N/A9/30/202013,6031,7301,6763,191N/A6/30/202013,1511,6491,0002,857N/A3/31/202012,9361,784-1741,784N/A12/31/201913,7851,841N/A2,851N/A9/30/201921,8922,931N/A2,910N/A6/30/201919,6572,546N/A2,536N/A3/31/201917,6032,157N/A2,097N/A12/31/201815,1291,937N/A1,625N/A9/30/20184,477464N/A600N/A6/30/20184,509441N/A636N/A3/31/20184,172397N/A526N/A12/31/20174,150385N/A356N/A9/30/20173,921339N/A391N/A6/30/20173,466302N/A431N/A3/31/20173,242-229N/A547N/A12/31/20162,844-304N/A615N/A9/30/20162,615-361N/A966N/A6/30/20162,553-346N/A527N/A3/31/20162,609183N/A343N/A12/31/20152,547254N/A242N/A9/30/20152,505363N/A120N/A6/30/20152,394387N/A206N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002064 의 연간 예상 수익 증가율(21.6%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002064 의 연간 수익(21.6%)이 CN 시장(27.2%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 002064 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 002064 의 수익(연간 4.8%)이 CN 시장(연간 16.3%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 002064 의 수익(연간 4.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002064의 자본 수익률은 3년 후 11.1%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/27 06:37종가2026/05/27 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Huafon Chemical Co.,Ltd는 11명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yilin HouChina International Capital Corporation LimitedDi WuChina International Capital Corporation LimitedXian Chao ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)8명의 분석가 더 보기
공시 • Apr 16Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026Huafon Chemical Co.,Ltd, Annual General Meeting, May 07, 2026, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China
공시 • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2026 Results on Apr 22, 2026Huafon Chemical Co.,Ltd announced that they will report Q1, 2026 results on Apr 22, 2026
공시 • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2025 Results on Mar 28, 2026Huafon Chemical Co.,Ltd announced that they will report fiscal year 2025 results on Mar 28, 2026
공시 • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2025 Results on Oct 25, 2025Huafon Chemical Co.,Ltd announced that they will report Q3, 2025 results on Oct 25, 2025
공시 • Sep 04Huafon Chemical Co.,Ltd Proposes Interim Cash Dividend for the Year 2025Huafon Chemical Co.,Ltd proposed interim cash dividend of CNY 0.50000000 per 10 shares for the year 2025.
공시 • Jul 02Huafon Chemical Co.,Ltd to Report First Half, 2025 Results on Aug 12, 2025Huafon Chemical Co.,Ltd announced that they will report first half, 2025 results on Aug 12, 2025
공시 • Apr 01Huafon Chemical Co.,Ltd Proposes Final Cash Dividend for the Year 2024Huafon Chemical Co.,Ltd announced that on 31 March 2025 the profit distribution proposal for 2024: Cash dividend (tax included) of CNY 1.50000000 per 10 shares.
공시 • Mar 31Huafon Chemical Co.,Ltd to Report Q1, 2025 Results on Apr 26, 2025Huafon Chemical Co.,Ltd announced that they will report Q1, 2025 results on Apr 26, 2025
공시 • Mar 29Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025Huafon Chemical Co.,Ltd, Annual General Meeting, Apr 24, 2025, at 15:00 China Standard Time. Location: 2F, Executive Building, No. 1688, Kaifaqu Avenue, Rui'an Economic Development Zone, Zhejiang China
공시 • Dec 31Huafon Chemical Co.,Ltd to Report Fiscal Year 2024 Results on Mar 29, 2025Huafon Chemical Co.,Ltd announced that they will report fiscal year 2024 results on Mar 29, 2025
공시 • Oct 31Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd.Huafon Chemical Co.,Ltd (SZSE:002064) agreed to acquire Zhejiang Huafon Thermoplastic Polyurethane Co., Ltd from Huafon Group Co., Ltd. on October 28, 2024. The consideration consist of cash and common equity.
공시 • Oct 30Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua.Huafon Chemical Co.,Ltd (SZSE:002064) signed a letter of intent to acquire Zhejiang Huafon Synthetic Resin Co., Ltd. from Huafon Group Co., Ltd., You Xiaoping, You Jinhuan and You Xiaohua on October 28, 2024. Huafon Chemical intends to acquire 100% of the equity of Zhejiang Huafon Synthetic Resin through issuing shares and paying cash. After the agreement is signed, both parties will continue to actively communicate, verify, and negotiate specific details of the transaction plan, transaction method, transaction price, share issuance price, share issuance quantity, and other matters, and will subsequently sign all formal agreements related to this transaction.
Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.10 (down from CN¥0.12 in 3Q 2023). Revenue: CN¥6.63b (down 6.1% from 3Q 2023). Net income: CN¥496.5m (down 13% from 3Q 2023). Profit margin: 7.5% (down from 8.1% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Huafon Chemical Co.,Ltd to Report Q3, 2024 Results on Oct 26, 2024Huafon Chemical Co.,Ltd announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥7.78, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.79 per share.
Reported Earnings • Aug 10Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥7.09b (up 10% from 2Q 2023). Net income: CN¥834.7m (up 15% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
공시 • Jun 29Huafon Chemical Co.,Ltd to Report First Half, 2024 Results on Aug 10, 2024Huafon Chemical Co.,Ltd announced that they will report first half, 2024 results on Aug 10, 2024
공시 • May 28Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024Huafon Chemical Co.,Ltd, Annual General Meeting, Jun 17, 2024, at 14:30 China Standard Time. Location: 2F, No. 1688, Development Zone Avenue, Economic Development Zone, Rui'an, Zhejiang China
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.13 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.13 in 1Q 2023). Revenue: CN¥6.66b (up 7.5% from 1Q 2023). Net income: CN¥683.4m (up 8.2% from 1Q 2023). Profit margin: 10% (in line with 1Q 2023). Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
공시 • Mar 30Huafon Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024
Valuation Update With 7 Day Price Move • Feb 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥6.99, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.68 per share.
공시 • Dec 30Huafon Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024Huafon Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.004 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.12 (up from CN¥0.004 in 3Q 2022). Revenue: CN¥7.06b (up 16% from 3Q 2022). Net income: CN¥569.9m (up CN¥548.7m from 3Q 2022). Profit margin: 8.1% (up from 0.3% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.21 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.21 in 2Q 2022). Revenue: CN¥6.43b (down 1.7% from 2Q 2022). Net income: CN¥727.2m (down 30% from 2Q 2022). Profit margin: 11% (down from 16% in 2Q 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.
공시 • Jul 01Huafon Chemical Co., Ltd. to Report First Half, 2023 Results on Aug 11, 2023Huafon Chemical Co., Ltd. announced that they will report first half, 2023 results on Aug 11, 2023
공시 • Jun 09Huafon Chemical Co., Ltd. Approves the Cash Dividend for the Year 2022Huafon Chemical Co., Ltd. approved the Cash dividend (tax included) of CNY 1.50000000 per 10 shares for the year 2022, at the AGM held on June 7, 2023.
공시 • May 19Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023Huafon Chemical Co., Ltd., Annual General Meeting, Jun 07, 2023, at 15:00 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual report and its summary; to consider 2022 annual accounts; to consider 2023 estimated continuing connected transactions; to consider confirmation of 2022 remuneration for directors, supervisors and senior management; and to consider other mattters.
Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.29 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.29 in 1Q 2022). Revenue: CN¥6.19b (down 15% from 1Q 2022). Net income: CN¥631.4m (down 54% from 1Q 2022). Profit margin: 10% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Dec 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.0%. The fair value is estimated to be CN¥9.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 19% in 2 years. Earnings is forecast to grow by 23% in the next 2 years.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.004 (vs CN¥0.49 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.004 (down from CN¥0.49 in 3Q 2021). Revenue: CN¥6.10b (down 25% from 3Q 2021). Net income: CN¥21.2m (down 99% from 3Q 2021). Profit margin: 0.3% (down from 28% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 05Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.48 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.48 in 2Q 2021). Revenue: CN¥6.54b (down 7.8% from 2Q 2021). Net income: CN¥1.03b (down 53% from 2Q 2021). Profit margin: 16% (down from 31% in 2Q 2021). The decrease in margin was primarily driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Jun 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.5%. The fair value is estimated to be CN¥10.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 58%. Revenue is forecast to grow by 6.4% in 2 years. Earnings is forecast to grow by 0.5% in the next 2 years.
Reported Earnings • May 02First quarter 2022 earnings released: EPS: CN¥0.29 (vs CN¥0.35 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.29 (down from CN¥0.35 in 1Q 2021). Revenue: CN¥7.29b (up 26% from 1Q 2021). Net income: CN¥1.36b (down 17% from 1Q 2021). Profit margin: 19% (down from 28% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Chu Yuxi is the most experienced director on the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥8.12b (up 111% from 3Q 2020). Net income: CN¥2.28b (up 295% from 3Q 2020). Profit margin: 28% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year and the company’s share price has also increased by 46% per year.
Reported Earnings • Aug 29Second quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.085 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.10b (up 104% from 2Q 2020). Net income: CN¥2.21b (up 463% from 2Q 2020). Profit margin: 31% (up from 11% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Apr 13Full year 2020 earnings released: EPS CN¥0.49 (vs CN¥0.43 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥14.7b (up 6.4% from FY 2019). Net income: CN¥2.28b (up 24% from FY 2019). Profit margin: 16% (up from 13% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥11.06, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 134% over the past three years.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥13.66, the stock is trading at a trailing P/E ratio of 35.3x, down from the previous P/E ratio of 42.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 170%.
Is New 90 Day High Low • Feb 20New 90-day high: CN¥16.20The company is up 56% from its price of CN¥10.41 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.24 per share.
Is New 90 Day High Low • Jan 21New 90-day high: CN¥13.52The company is up 81% from its price of CN¥7.47 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.05 per share.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥12.26, the stock is trading at a trailing P/E ratio of 31.7x, up from the previous P/E ratio of 26.1x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 148%.
Is New 90 Day High Low • Jan 06New 90-day high: CN¥11.51The company is up 56% from its price of CN¥7.40 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.07 per share.
Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥9.85, the stock is trading at a trailing P/E ratio of 25.5x, up from the previous P/E ratio of 21.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 111%.
Is New 90 Day High Low • Nov 09New 90-day high: CN¥8.99The company is up 25% from its price of CN¥7.20 on 11 August 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.57 per share.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.11b, down 17% from the prior year. Total revenue was CN¥15.8b over the last 12 months, down 19% from the prior year.